Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system (CNS). The coexistence of NMOSD and other autoimmune diseases is well recognized. Additionally, rare cases of NMOSD complicated by posterior reversible encephalopathy syndrome (PRES) have been reported. We present here a case of a young female who developed NMOSD in the clinical course of Sjögren's syndrome (SS) and autoimmune hepatitis (AIH), and who then rapidly developed PRES. A 28-year-old woman was admitted to our hospital with complaints of nausea and singultus, resulting in difficulty eating. She had been experiencing numbness from her neck to her upper arms prior to admission, and she also developed a decrease in visual acuity in her left eye after admission. Brain magnetic resonance imaging (MRI) revealed optic neuritis and a lesion in the area postrema. Based on these imaging findings and those symptoms described as acute myelitis, she was tentatively diagnosed with NMOSD, and treatment with steroids and plasmapheresis was initiated. The following day, however, she developed status epilepticus. Follow-up MRI showed edematous changes in the cortex and deep white matter of the frontal, parietal, and occipital lobes, as well as in the basal ganglia and cerebellum, accompanied by hemorrhage and meningeal enhancement. Her serum test turned out to be positive for anti-aquaporin-4 antibody later. Finally, she was diagnosed with PRES accompanied by NMOSD. It is of note to consider NMOSD when patients with autoimmune diseases present with neurological symptoms such as optic neuritis or acute myelitis. Based on previous reports and temporal changes in her antibody titers, SS may have been involved in the onset of NMOSD in this case. When NMOSD complicates SS, it can be challenging to distinguish CNS lesions caused by SS from those caused by NMOSD. Although previous reports on the coexistence of NMOSD and PRES are limited, several factors have been proposed to explain the mechanism underlying this pathology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11865253PMC
http://dx.doi.org/10.7759/cureus.78098DOI Listing

Publication Analysis

Top Keywords

nmosd
11
neuromyelitis optica
8
optica spectrum
8
spectrum disorder
8
complicated posterior
8
posterior reversible
8
reversible encephalopathy
8
encephalopathy syndrome
8
sjögren's syndrome
8
syndrome autoimmune
8

Similar Publications

Background: Epidemiological studies of neuromyelitis optica spectrum disorder (NMOSD) show variability due to differences in methodologies, diagnostic criteria, and geographic factors.

Objective: This study aimed to determine NMOSD's epidemiological profile in Türkiye using official health records covering over 95 % of the population.

Methods: Data were collected using ICD-10 codes (G36.

View Article and Find Full Text PDF

Background And Purpose: Treatments for neuromyelitis optica spectrum disorder (NMOSD) such as eculizumab, ravulizumab, satralizumab, and inebilizumab have significantly advanced relapse prevention, but they remain expensive. Rituximab is an off-label yet popular alternative that offers a cost-effective solution, but its real-world efficacy needs better quantification for guiding the application of newer approved NMOSD treatments (ANTs). This study aimed to determine real-world rituximab failure rates to anticipate the demand for ANTs and aid in resource allocation.

View Article and Find Full Text PDF

Background: Studies in MS and NMOSD have shown that relapses can frequently occur in the same location as the first attack. Factors associated with this outcome in MOGAD are unclear.

Objective: The objective of this study was to investigate the likelihood of a relapse occurring at the same site in MOGAD.

View Article and Find Full Text PDF

Background And Objectives: Transverse myelitis (TM) is a rare neuro-inflammatory condition of the spinal cord that can cause chronic and debilitating symptoms reducing quality of life. TM is understudied in developing regions worldwide, particularly in Latin America and the Caribbean (LAC), where the prevalence of TM is unknown. Etiologies of TM are variable, but certain infectious, autoimmune or nutritional abnormalities may be more common in LAC with differing estimated prevalences of these etiologies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!